An observational study in Necrotizing Enterocolitis, Intraventricular Hemorrhage and BPD - Bronchopulmonary Dysplasia, sponsored by The First Hospital of Jilin University. Not yet recruiting. Per ClinicalTrials.gov, last updated 2023-09-21.
Sponsored by The First Hospital of Jilin University · Observational
The research endeavors to examine the critical composition of Polyunsaturated Fatty Acids (PUFAs) in premature infants across different gestational stages and under varying disease conditions, and delineate the metabolic attributes of PUFAs in premature infants and their interplay with the onset of diseases. This study anticipates furnishing a theoretical foundation for the rationalization of PUFAs supplementation in premature infants and for informing strategies related to disease prevention and management.
228 studies on the registry are indexed under Enterocolitis, Necrotizing; 44 are open to participants now.
This study's planned enrollment of 600 is above the median of 144 across 95 observational studies indexed under Enterocolitis, Necrotizing.
Browse Enterocolitis, Necrotizing studies →The First Hospital of Jilin University is the lead sponsor of 185 studies on the registry; 96 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Neonates born within 24 hours who were admitted to the Neonatology Department of the First Hospital of Jilin University, including premature infants born between 24 and 36 weeks of gestational age and full-term infants from September 2023 to August 2026, n
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Infants born between 24 and 36 weeks of gestational age who are admitted within 24 hours of birth, including both premature and full-term newborns.
-
Exclusion Criteria:
Infants with severe congenital developmental abnormalities, those requiring external supplementation of PUFAs in addition to standard intravenous nutrition and breastfeeding, and those with a severe prognosis indicating non-survival during their hospitalization.
-
Mortality and severe complications of premature infants
incidence of death，NEC，PDA，BPD，IVH，PVL and sepsis
Time frame: before discharge
Mortality
death
Time frame: before discharge
NEC
Bell stage II or III
Time frame: before discharge
PDA
confirmed by echocardiography
Time frame: before discharge
BPD
nasal CPAP/NIPPV or invasive ventilation requirement at 36 weeks postmenstrual age or at discharge, transfer or death if before 36 weeks
Time frame: before discharge
IVH
Papile grades 3-4
Time frame: before discharge
PVL
periventricular cysts on cranial ultrasound or magnetic resonance imaging
Time frame: before discharge
sepsis
blood culture positive
Time frame: before discharge
No study locations are listed for this record.
This study is not yet recruiting, as verified in Aug 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
The First Hospital of Jilin University →